Sanofi gears to leverage Evolutive Vaccine Facility (EVF) in Asia by 2025

Vaccines |  News | 0 Comment

On 20 April 2022, Sanofi launched Evolutive Vaccine Facility (EVF) in Singapore. A first-of-its-kind, the...Read more

Japan grants marketing authorisation to Sanofi's rare disease drug

Japan |  News | 0 Comment

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorisation for Xenpozyme (olipu...Read more

China's Adagene partners with French firm Sanofi for Immuno-Oncology

China |  News | 0 Comment

China's Adagene,  a company transforming the discovery and development of antibody-based therapies, has announced a...Read more

Korean firm partners with Sanofi for Parkinson's Disease treatment

Therapeutics |  News | 0 Comment

ABL Bio, Inc., a South Korea-based clinical-stage biotech developing bispecific antibody technology for immuno-oncology ...Read more

Manager for Launch Excellence at Sanofi, Japan

Bio Jobs |  News | 0 Comment

Apply Now ! About the job Experience Requirements: 3⁺ years of marketing experience in ethical pharma business ...Read more

Sanofi invests €400 M in first-of-its kind vaccines mRNA Center of Excellence

World |  News | 0 Comment

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. ...Read more

RSF Bio enters worldwide license agreement with Sanofi for cardiovascular drug

New Drug Applications |  News | 0 Comment

Rancho Santa Fe Bio, Inc. (RSF Bio), a San Diego, California-based clinical-stage cardiovascular platform company, annou...Read more

Sanofi and C4X Discovery ink €414 M worldwide licensing deal

Europe |  News | 0 Comment

Sanofi and drug discovery company C4X Discovery (C4XD) have entered an exclusive worldwide licensing agreement worth up ...Read more

Sanofi invests in Asia's first digitally-enabled vaccine production center in Singapore

Singapore |  News | 0 Comment

Sanofi has announced a €400 million investment over five years to create a unique vaccine production center in Sing...Read more

Daiichi Sankyo incurs 15 B yen loss after terminating vaccine biz with Sanofi

Japan |  News | 0 Comment

Daiichi Sankyo Company, Ltd. has announced that it will terminate its marketing alliance agreement for the Squarekids&re...Read more